Who Owns Ingevity Company?

Ingevity Bundle

Get Full Bundle:

	SWOT	$15	$10
	5 FORCES	$15	$10
	BCG	$15	$10
	CANVAS	$15	$10
	4P's MIX	$15	$10
	PESTLE	$15	$10

TOTAL:

ADD TO CART

Who Really Owns Ingevity?

Understanding the ownership structure of a company like Ingevity Corporation is crucial for investors and analysts alike. From its roots in the 19th century to its current status, Ingevity's journey offers a fascinating case study in corporate evolution. Knowing Ingevity SWOT Analysis can help you with your investment decisions. This exploration unveils the key players and pivotal moments that have shaped Ingevity's destiny.

Ingevity's story began with its spin-off from WestRock Company in May 2016, transforming it into a standalone, publicly traded entity. Today, with a market cap of approximately $1.59 billion and around 1,600 employees, Ingevity's ownership structure is a key factor in understanding its strategic direction. Delving into the details of who owns Ingevity, including its major investors and public shareholders, provides critical insights into the company's future, its financial performance and Ingevity stock.

The story of Ingevity's brief history and its ownership structure differs from that of a typical startup. Instead of a single founder, Ingevity's origins are rooted in the evolution of larger companies in the paper and pulp industry. This unique beginning shapes how we understand who owns Ingevity and the company's early ownership dynamics.

Ingevity Corporation's roots trace back to the mid-1800s, with the formal incorporation of SCD businesses in 1964. Before becoming Ingevity in 2016, the business operated under various names, including Westvaco, MeadWestvaco, and MWV. These early businesses focused on paper production, viewing by-products as opportunities, which laid the foundation for Ingevity's current specialty chemical focus.

The company's structure as a standalone entity began with its spin-off from WestRock Company in May 2016. WestRock shareholders received one share of Ingevity common stock for every six common shares of WestRock they held. This distribution established the initial public ownership of Ingevity, with former WestRock shareholders becoming Ingevity's first public shareholders. Therefore, the question of who owns Ingevity is primarily answered by looking at its public shareholders.

Ownership Structure Insights

Understanding Ingevity's ownership structure is key to analyzing its stock. As a publicly traded company, Ingevity's major investors include institutional investors and the general public. Here's a breakdown:

• Ingevity shareholders consist primarily of institutional investors, mutual funds, and individual investors who own shares of Ingevity stock.
• The company's stock symbol is ING.
• The Ingevity company structure reflects a standard corporate governance model, with a board of directors overseeing the company's operations.
• Information on Ingevity's financial performance can be found in its annual reports.

Ingevity SWOT Analysis

• Complete SWOT Breakdown
• Fully Customizable
• Editable in Excel & Word
• Professional Formatting
• Investor-Ready Format

GET TEMPLATE ➔

The journey of Ingevity Corporation began on May 16, 2016, as a publicly traded entity after spinning off from WestRock Company. The company's stock began trading on the New York Stock Exchange (NYSE) under the ticker 'NGVT.' At its inception, the market capitalization of Ingevity was approximately $1.13 billion. This marked the start of its independent operation and set the stage for changes in its ownership structure over time.

Since its initial public offering (IPO), the ownership of Ingevity has primarily shifted towards institutional investors. As of June 4, 2025, there are 581 institutional owners and shareholders holding a total of 48,323,719 shares. The largest institutional shareholders as of March 31, 2025, include BlackRock, Inc., holding 5,714,888 shares (or 15.02% of total shares outstanding), Vanguard Group Inc. with 4,083,386 shares (11.23%), and Wellington Management Group Llp with 2,299,312 shares (6.325%). These shifts reflect the typical trends seen in publicly traded companies, where institutional investors often acquire significant stakes.

The management of Ingevity has undertaken strategic initiatives to address market challenges and enhance shareholder value. In January 2025, the company announced it was exploring strategic alternatives for its Performance Chemicals Industrial Specialties product line, including a potential divestiture of portions of its North Charleston site. This move is aimed at strengthening the segment and improving overall earnings and cash flow, demonstrating the company's proactive approach to portfolio management. For more details, you can check out the Marketing Strategy of Ingevity.

Key Takeaways on Ingevity Ownership

Ingevity's ownership structure has evolved since its IPO, with a significant shift towards institutional investors. The largest shareholders include BlackRock, Vanguard, and Wellington Management. The company is actively managing its portfolio to enhance profitability and shareholder value.

• Institutional investors hold the majority of Ingevity shares.
• Management focuses on operational performance and free cash flow.
• Strategic decisions aim to strengthen core business segments.
• The company is listed on the NYSE under the symbol 'NGVT'.

Ingevity PESTLE Analysis

• Covers All 6 PESTLE Categories
• No Research Needed – Save Hours of Work
• Built by Experts, Trusted by Consultants
• Instant Download, Ready to Use
• 100% Editable, Fully Customizable

GET TEMPLATE ➔

As of April 30, 2025, the Board of Directors for the company, was approved to increase from nine to eleven members. The Board plays a crucial role in overseeing the company's strategy and governance. The Board's recommended nominees for election at the 2025 annual meeting included Jean S. Blackwell, Luis Fernandez-Moreno, Diane H. Gulyas, Bruce D. Hoechner, Frederick J. Lynch, Karen G. Narwold, Daniel F. Sansone, J. Kevin Willis, and Benjamin G. (Shon) Wright. J. Kevin Willis was appointed to the board in December 2024, bringing significant chemical industry, finance, and capital management expertise. Luis Fernandez-Moreno, who served as interim President and CEO from October 2024 to April 2025, remains on the Board.

David H. Li was appointed as the new President and CEO, effective April 7, 2025, and is expected to join the board after the 2025 Annual Meeting. F. David Segal was also appointed to the board in April 2025 as a result of a cooperation agreement with activist investor Vision One.

Regarding voting power, the company operates under a one-share, one-vote system for its common stock. Shareholders vote on matters such as the election of directors and other proposals at the annual meeting. The company's proxy materials for the 2025 Annual Meeting of Stockholders, held virtually on April 30, 2025, outlined the voting procedures. Shareholders were urged to vote 'FOR' the nine nominees recommended by the Board. A recent development impacting the Board and voting power involves activist investor Vision One, which beneficially owned 1.15% of the company's shares as of February 2025. This engagement highlights the influence of activist investors in shaping governance and decision-making within the company. For more information about the company's target market, you can read this article: Target Market of Ingevity.

Key Takeaways

The Board of Directors oversees the company's strategy and governance.

• The board consists of eleven members as of April 30, 2025.
• Shareholders vote on key matters, including director elections.
• Activist investor involvement influences governance and decision-making.
• The company operates under a one-share, one-vote system.

Ingevity Business Model Canvas

• Complete 9-Block Business Model Canvas
• Effortlessly Communicate Your Business Strategy
• Investor-Ready BMC Format
• 100% Editable and Customizable
• Clear and Structured Layout

GET TEMPLATE ➔

Over the past few years, the Ingevity ownership structure and strategic direction have seen notable shifts. The company has undergone significant leadership changes, including the appointment of David H. Li as President and CEO, effective April 7, 2025. This follows a period where Luis Fernandez-Moreno served as interim CEO. Simultaneously, Ingevity has been actively reviewing its portfolio, with plans announced in January 2025 to explore strategic alternatives for parts of its Performance Chemicals Segment. These moves are aimed at enhancing profitability and streamlining operations, influencing the Ingevity stock performance.

A key trend in Ingevity corporation is the increased involvement of activist investors. Vision One Fund, holding approximately 1.15% of the shares, nominated directors for the 2025 Annual Meeting, highlighting concerns about the company's strategy. This engagement resulted in a cooperation agreement and the appointment of F. David Segal to the Board. This reflects a broader trend, with over 240 activist campaigns globally in 2024, indicating a focus on driving strategic changes and maximizing shareholder value. The company's strategic and leadership changes aim to drive profitable growth and sustainable value creation for Ingevity shareholders.

Furthermore, Ingevity's financial performance in 2024, with an adjusted EBITDA of $363 million and $51 million in free cash flow, has set the stage for expected growth in 2025. The company projects an adjusted EBITDA between $400 million and $415 million and free cash flow between $220 million and $260 million for the full year 2025. These forecasts are supported by strategic initiatives like portfolio optimization and leadership transitions, which are critical for understanding the Ingevity ownership dynamics and future prospects. For more insights into the company's operations, consider exploring the Revenue Streams & Business Model of Ingevity.

Who is the CEO of Ingevity?

David H. Li was appointed President and CEO, effective April 7, 2025.

Is Ingevity a public company?

Yes, Ingevity is a publicly traded company.

What is Ingevity's stock symbol?

The stock symbol for Ingevity is currently not provided, but can be found on major financial platforms.

Who are Ingevity's major investors?

Major investors include institutional investors and activist funds like Vision One Fund.

Ingevity Porter's Five Forces Analysis

• Covers All 5 Competitive Forces in Detail
• Structured for Consultants, Students, and Founders
• 100% Editable in Microsoft Word & Excel
• Instant Digital Download – Use Immediately
• Compatible with Mac & PC – Fully Unlocked

GET TEMPLATE ➔

Related Blogs